Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06550674
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-05
Brief Title:
Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IGCMU
Brief Summary:
Only 20 of familial uveal melanomas are explained by a hereditary predisposition implying the presence of as yet unknown hereditary predispositions This hypothesis is reinforced by epidemiological studies revealing an excess risk of prostate cancer thyroid cancer and leukemia in patients who have developed uveal melanoma even though these cancers are not part of the tumor spectrum of known hereditary predispositions to uveal melanoma BAP1 MBD4 The identification of new candidate genes once validated would enable us to offer these families appropriate surveillance
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None